Clinical Trials Link
Primary Protocol Team Members
P1107 is multi-center observational study that will describe the outcomes of up to 25 participants from the US living with HIV, ages 12 months and older, who undergo transplantation with CCR5Δ32 cord blood stem cells for treatment of cancer, hematopoietic disease, or other underlying disease.
15 February 2022: IMPAACT P1107 Team Presents First Known Case of a Woman with HIV Remission
>> Learn More